Siehe auch...
ACOT1 Antikörper
Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|---|
ACOT1/2 Antikörper (F-2) | sc-373917 | mouse IgG1 κ | 249-324 (h) | WB, IP, IF, IHC(P), ELISA | h | 3 | ||
ACOT1/2 Antikörper (E-1) | sc-373919 | mouse IgG2b κ | 249-324 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 | ||
ACOT1/2 Antikörper (F-6) | sc-398505 | mouse IgG2a κ | 252-271 (h) | WB, IP, IF, ELISA | h | neu |
ACOT1 CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
ACOT1 CRISPR/Cas9 KO Plasmid (m) | sc-424125 | m | Gene Knockout | GFP | 0 | ||
ACOT1 HDR Plasmid (m) | sc-424125-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ACOT1 Double Nickase Plasmid (m) | sc-424125-NIC | m | Gene Knockout | Puromycin | 0 | ||
ACOT1 Double Nickase Plasmid (m2) | sc-424125-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ACOT1 CRISPR Activation Products
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
ACOT1 CRISPR Activation Plasmid (m) | sc-424125-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACOT1 CRISPR Activation Plasmid (m2) | sc-424125-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACOT1 Lentiviral Activation Particles (m) | sc-424125-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ACOT1 Lentiviral Activation Particles (m2) | sc-424125-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
ACOT1 siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
ACOT1 siRNA (m) | sc-72434 | m | Gene Silencing | N/A | 0 | ||
ACOT1 shRNA Plasmid (m) | sc-72434-SH | m | Gene Silencing | Puromycin | 0 | ||
ACOT1 shRNA (m) Lentivirale Partikel | sc-72434-V | m | Gene Silencing | Puromycin | 0 |